Clinical trial Q&A: New data on DOT lenses show strong global performance in myopia control

Published on May 27, 2025
New data from North American and Chinese clinical trials reinforce the safety, efficacy, and durability of DOT lenses in slowing pediatric myopia progression, without evidence of rebound.
Continue reading on website
Other news

Kering Eyewear and Google partner for smart eyewear

May 27, 2025
The partnership will focus on the development of AI-powered glasses with Android XR

ARVO 2025: The early adoption and utilization of perfluorohexoloctane (Miebo)

May 27, 2025
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.